Department of Cardiology - Cardiology I, University Medical Center, Johannes Gutenberg University Mainz, Langenbeckstr. 1, 55131, Mainz, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Mainz, Germany.
Clin Res Cardiol. 2022 Mar;111(3):272-283. doi: 10.1007/s00392-021-01879-y. Epub 2021 Jun 24.
To assess the prevalence of type 2 diabetes mellitus (T2DM) and prediabetes in the general population and to investigate the associated cardiovascular burden and clinical outcome.
The study sample comprised 15,010 individuals aged 35-74 years of the population-based Gutenberg Health Study. Subjects were classified into euglycaemia, prediabetes and T2DM according to clinical and metabolic (HbA1c) information. The prevalence of prediabetes was 9.5% (n = 1415) and of T2DM 8.9% (n = 1316). Prediabetes and T2DM showed a significantly increased prevalence ratio (PR) for age, obesity, active smoking, dyslipidemia, and arterial hypertension compared to euglycaemia (for all, P < 0.0001). In a robust Poisson regression analysis, prediabetes was established as an independent predictor of clinically-prevalent cardiovascular disease (PR 1.20, 95% CI 1.07-1.35, P = 0.002) and represented as a risk factor for asymptomatic cardiovascular organ damage independent of traditional risk factors (PR 1.04, 95% CI 1.01-1.08, P = 0.025). Prediabetes was associated with a 1.5-fold increased 10-year risk for cardiovascular disease compared to euglycaemia. In Cox regression analysis, prediabetes (HR 2.10, 95% CI 1.76-2.51, P < 0.0001) and T2DM (HR 4.28, 95% CI 3.73-4.92, P < 0.0001) indicated for an increased risk of death. After adjustment for age, sex and traditional cardiovascular risk factors, only T2DM (HR 1.89, 95% CI 1.63-2.20, P < 0.0001) remained independently associated with increased all-cause mortality.
Besides T2DM, also prediabetes inherits a significant cardiovascular burden, which translates into poor clinical outcome and indicates the need for new concepts regarding the prevention of cardiometabolic disorders.
评估 35-74 岁一般人群中 2 型糖尿病(T2DM)和糖尿病前期的患病率,并探讨相关的心血管负担和临床结局。
本研究样本包括人群基础的哥廷根健康研究中的 15010 名 35-74 岁的个体。根据临床和代谢(HbA1c)信息,受试者被分为血糖正常、糖尿病前期和 T2DM。糖尿病前期的患病率为 9.5%(n=1415),T2DM 的患病率为 8.9%(n=1316)。与血糖正常相比,糖尿病前期和 T2DM 的年龄、肥胖、主动吸烟、血脂异常和动脉高血压的流行比率(PR)显著增加(所有 P<0.0001)。在稳健的泊松回归分析中,糖尿病前期被确定为临床常见心血管疾病的独立预测因子(PR 1.20,95%CI 1.07-1.35,P=0.002),并且作为独立于传统危险因素的无症状心血管器官损害的危险因素(PR 1.04,95%CI 1.01-1.08,P=0.025)。与血糖正常相比,糖尿病前期使心血管疾病的 10 年风险增加了 1.5 倍。在 Cox 回归分析中,糖尿病前期(HR 2.10,95%CI 1.76-2.51,P<0.0001)和 T2DM(HR 4.28,95%CI 3.73-4.92,P<0.0001)提示死亡风险增加。在调整年龄、性别和传统心血管危险因素后,只有 T2DM(HR 1.89,95%CI 1.63-2.20,P<0.0001)仍与全因死亡率增加独立相关。
除 T2DM 外,糖尿病前期也具有显著的心血管负担,这转化为不良的临床结局,并表明需要针对心脏代谢疾病的预防提出新的概念。